\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ discontinuous\\ nodular\\ enhancement\\ on\\ contrast\\ enhanced\\ ct\\ with\\ positive\\ nm\\ rbc\\ scan\\.\ \(0\)\
\-\ hepatic\\ hemangioma\ \(3\)\
\-\ hemangioma\ \(165\)\
\-\ \\(hepatocellular\\ carinoma\\,fnh\\,hepatic\\ adenoma\\,hypervascular\\ metastases\\ would\\ not\\ be\\ expected\\ to\\ have\\ positive\\ rbc\\ scan\\,\\ although\\ could\\ potentially\\ have\\ similar\\ appearance\\ on\\ ct\\)\ \(0\)\
\-\ abnormal\\ hepatic\\ finding\\ on\\ ct\\ scan\\ in\\ patient\\ with\\ abdominal\\ pain\\.\ \(0\)\
\-\ a\\ hemangioma\\ is\\ defined\\ pathologically\\ as\\ a\\ tumor\\ composed\\ of\\ multiple\\ vascular\\ channels\\ lined\\ by\\ a\\ single\\ layer\\ of\\ endothelial\\ cells\\ supported\\ by\\ a\\ thin\\,\\ fibrous\\ stroma\\.\\ \\ they\\ are\\ divided\\ into\\ two\\ catagories\\;\\ typical\\ and\\ giant\\.\\ \\ typical\\ hemangiomas\\ are\\ small\\,\\ asymptomatic\\ and\\ discovered\\ incidentally\\.\\ \\ giant\\ hemangiomas\\ are\\ \\>5\\ cm\\ and\\ may\\ hemorrhage\\ or\\ thrombose\\.\ \(0\)\
\-\ ct\\ findings\\ include\\ a\\ hypodense\\,\\ well\\ circumscribed\\ lesion\\ on\\ pre\\-contrast\\ ct\\ with\\ nodular\\ intense\\ peripheral\\ enhancement\\ on\\ dynamic\\ bolus\\ contrast\\ phase\\.\\ \\ nuclear\\ spect\\ imaging\\ \\ shows\\ increased\\ activity\\ of\\ 99\\-tc\\ labled\\ rbc\\'s\\ on\\ delayed\\ blood\\ pool\\ imaging\\;\\ however\\,\\ this\\ study\\ is\\ only\\ useful\\ if\\ the\\ tumor\\ in\\ question\\ is\\ 2\\-3\\ cm\\ or\\ greater\\ in\\ size\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rbc\\:\\ 0\\.27054617946348525\ \(0\)\
\-\ hemangioma\\:\\ 0\\.22623840994516242\ \(0\)\
\-\ hepatic\\:\\ 0\\.21418152012298408\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.1958923879865061\ \(0\)\
\-\ ct\\:\\ 0\\.1706556318539727\ \(0\)\
\-\ on\\:\\ 0\\.16245755400639247\ \(0\)\
\-\ giant\\:\\ 0\\.15993765607416036\ \(0\)\
\-\ scan\\:\\ 0\\.15956752531916288\ \(0\)\
\-\ catagories\\:\\ 0\\.1433720917844811\ \(0\)\
\-\ thrombose\\:\\ 0\\.1433720917844811\ \(0\)\
\-\ labled\\:\\ 0\\.1433720917844811\ \(0\)\
\-\ nodular\\:\\ 0\\.1427876800819894\ \(0\)\
\-\ typical\\:\\ 0\\.13857030339831336\ \(0\)\
\-\ carinoma\\:\\ 0\\.13247839518909485\ \(0\)\
\-\ contrast\\:\\ 0\\.13067934168241693\ \(0\)\
\-\ discontinuous\\:\\ 0\\.12158469859370863\ \(0\)\
\-\ positive\\:\\ 0\\.11815132496213758\ \(0\)\
\-\ channels\\:\\ 0\\.11657978993394673\ \(0\)\
\-\ bolus\\:\\ 0\\.11657978993394673\ \(0\)\
\-\ nm\\:\\ 0\\.11521229459117395\ \(0\)\
\-\ fnh\\:\\ 0\\.1127896190280214\ \(0\)\
\-\ endothelial\\:\\ 0\\.1127896190280214\ \(0\)\
\-\ lined\\:\\ 0\\.10799015488921943\ \(0\)\
\-\ stroma\\:\\ 0\\.10568609333856048\ \(0\)\
\-\ supported\\:\\ 0\\.10498747690015037\ \(0\)\
\-\ pathologically\\:\\ 0\\.10431859799578772\ \(0\)\
\-\ enhancement\\:\\ 0\\.10320356033003175\ \(0\)\
\-\ cm\\:\\ 0\\.10297562195545255\ \(0\)\
\-\ spect\\:\\ 0\\.1024674865861046\ \(0\)\
\-\ are\\:\\ 0\\.10205587698288068\ \(0\)\
\-\ dynamic\\:\\ 0\\.10134441735279506\ \(0\)\
\-\ layer\\:\\ 0\\.09979730540293616\ \(0\)\
\-\ divided\\:\\ 0\\.09979730540293616\ \(0\)\
\-\ composed\\:\\ 0\\.09751558398689188\ \(0\)\
\-\ hypervascular\\:\\ 0\\.09479239674317425\ \(0\)\
\-\ imaging\\:\\ 0\\.09422968022984735\ \(0\)\
\-\ potentially\\:\\ 0\\.09409378030476413\ \(0\)\
\-\ pool\\:\\ 0\\.09409378030476413\ \(0\)\
\-\ tumor\\:\\ 0\\.09378575831200285\ \(0\)\
\-\ question\\:\\ 0\\.09247210774444986\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.09216692763014925\ \(0\)\
\-\ have\\:\\ 0\\.08957157490514092\ \(0\)\
\-\ hypodense\\:\\ 0\\.08705249739786682\ \(0\)\
\-\ useful\\:\\ 0\\.08559431350538914\ \(0\)\
\-\ nuclear\\:\\ 0\\.08481804303115034\ \(0\)\
\-\ intense\\:\\ 0\\.08462982183471424\ \(0\)\
\-\ discovered\\:\\ 0\\.08173325261885257\ \(0\)\
\-\ expected\\:\\ 0\\.08082629242220046\ \(0\)\
\-\ phase\\:\\ 0\\.07671420425318402\ \(0\)\
\-\ incidentally\\:\\ 0\\.07637861252624664\ \(0\)\
\-\ by\\:\\ 0\\.0761423605498068\ \(0\)\
\-\ is\\:\\ 0\\.07365492776366114\ \(0\)\
\-\ metastases\\:\\ 0\\.07247815146907577\ \(0\)\
\-\ adenoma\\:\\ 0\\.07147464372570131\ \(0\)\
\-\ delayed\\:\\ 0\\.07015447643520846\ \(0\)\
\-\ thin\\:\\ 0\\.0697863967999459\ \(0\)\
\-\ fibrous\\:\\ 0\\.06964154524871222\ \(0\)\
\-\ circumscribed\\:\\ 0\\.06942674078342514\ \(0\)\
\-\ cells\\:\\ 0\\.06907513144169394\ \(0\)\
\-\ single\\:\\ 0\\.06893666110052606\ \(0\)\
\-\ similar\\:\\ 0\\.06832821290746822\ \(0\)\
\-\ enhanced\\:\\ 0\\.06826203899052483\ \(0\)\
\-\ in\\:\\ 0\\.06690706976457185\ \(0\)\
\-\ greater\\:\\ 0\\.06604828384839175\ \(0\)\
\-\ activity\\:\\ 0\\.06582050765779779\ \(0\)\
\-\ could\\:\\ 0\\.06521062830487419\ \(0\)\
\-\ peripheral\\:\\ 0\\.06410820012313845\ \(0\)\
\-\ they\\:\\ 0\\.06405758403412175\ \(0\)\
\-\ defined\\:\\ 0\\.06395683829134975\ \(0\)\
\-\ would\\:\\ 0\\.06346257485172287\ \(0\)\
\-\ or\\:\\ 0\\.06237624530289205\ \(0\)\
\-\ although\\:\\ 0\\.06103294979384946\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.06103294979384946\ \(0\)\
\-\ size\\:\\ 0\\.060702936995480905\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.06002385602516112\ \(0\)\
\-\ study\\:\\ 0\\.05979101795829115\ \(0\)\
\-\ vascular\\:\\ 0\\.059186471039190336\ \(0\)\
\-\ finding\\:\\ 0\\.058929122658995796\ \(0\)\
\-\ only\\:\\ 0\\.05600910357057784\ \(0\)\
\-\ and\\:\\ 0\\.05557608721583614\ \(0\)\
\-\ appearance\\:\\ 0\\.054047349078254536\ \(0\)\
\-\ abnormal\\:\\ 0\\.05386135540390495\ \(0\)\
\-\ include\\:\\ 0\\.0533417615676276\ \(0\)\
\-\ two\\:\\ 0\\.05323987283439905\ \(0\)\
\-\ however\\:\\ 0\\.05306314169596352\ \(0\)\
\-\ with\\:\\ 0\\.05266458964851519\ \(0\)\
\-\ of\\:\\ 0\\.052633141359094915\ \(0\)\
\-\ shows\\:\\ 0\\.05261761095291818\ \(0\)\
\-\ if\\:\\ 0\\.05208968619566383\ \(0\)\
\-\ blood\\:\\ 0\\.0520661058730781\ \(0\)\
\-\ abdominal\\:\\ 0\\.04903272401505787\ \(0\)\
\-\ increased\\:\\ 0\\.04847920939462197\ \(0\)\
\-\ into\\:\\ 0\\.04765713625562153\ \(0\)\
\-\ small\\:\\ 0\\.0462452069503835\ \(0\)\
\-\ may\\:\\ 0\\.045115406975191605\ \(0\)\
\-\ findings\\:\\ 0\\.044246557522056654\ \(0\)\
\-\ multiple\\:\\ 0\\.0438504466380072\ \(0\)\
\-\ well\\:\\ 0\\.04340964559137425\ \(0\)\
\-\ lesion\\:\\ 0\\.04298087132048235\ \(0\)\
\-\ be\\:\\ 0\\.03636798536541911\ \(0\)\
\-\ as\\:\\ 0\\.03601614562977962\ \(0\)\
\-\ not\\:\\ 0\\.03539223668526361\ \(0\)\
\-\ pain\\:\\ 0\\.032080567080661974\ \(0\)\
\-\ this\\:\\ 0\\.03080583252520528\ \(0\)\
\-\ patient\\:\\ 0\\.029159096974185773\ \(0\)\
\-\ to\\:\\ 0\\.02241267171193854\ \(0\)\
\-\ the\\:\\ 0\\.017888701044264946\ \(0\)\
